cyproterone acetate has been researched along with Bone Loss, Perimenopausal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Liang, J; Liu, H; Wang, X; Wu, X; Xu, Y | 1 |
| Alhava, E; Heikkinen, AM; Honkanen, R; Jurvelin, J; Komulainen, M; Kröger, H; Puntila, E; Saarikoski, S; Tuppurainen, MT | 1 |
| Alhava, E; Heikkinen, AM; Honkanen, R; Jurvelin, J; Komulainen, M; Kröger, H; Saarikoski, S; Tuppurainen, MT | 1 |
| Heikkinen, AM; Honkanen, R; Komulainen, M; Kröger, H; Mäenpää, PH; Mahonen, A; Saarikoski, S; Salmén, T | 1 |
| Schneider, HP | 1 |
| Christiansen, C; Marslew, U; Overgaard, K; Riis, BJ | 1 |
1 review(s) available for cyproterone acetate and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The role of antiandrogens in hormone replacement therapy.
Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome | 2000 |
5 trial(s) available for cyproterone acetate and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints.
Topics: Acupuncture Points; Acupuncture Therapy; Aged; Biomarkers; Bone Density; Catgut; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Quality of Life; Single-Blind Method | 2020 |
Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Topics: Androgen Antagonists; Bone Density; Cholecalciferol; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Humans; Middle Aged; Osteoporosis, Postmenopausal; Statistics, Nonparametric | 1998 |
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
Topics: Cholecalciferol; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause | 1999 |
The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Topics: Androgen Antagonists; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Replacement Therapy; Female; Follow-Up Studies; Fractures, Bone; Genotype; Humans; Middle Aged; Osteoporosis, Postmenopausal; Polymorphism, Genetic; Receptors, Estrogen; Risk | 2000 |
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Bone and Bones; Bone Density; Calcium; Climacteric; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Uterine Hemorrhage | 1992 |